purpose to provide a comprehensive overview of the current main applications of long axial feld-of-view (LAFOV) PET/ CT in oncology. methods relevant studies published from 2017 up to september 2022 were selected by searching scopus, pubmed, and web of science. the following data were extracted: characteristics of studies and patients, technical aspects, and usefulness of the LAFOV PET/CT in the oncological setting. selected imaging studies were analyzed using a modifed version of the critical appraisal Skills Programme (CASP). results seventeen papers were fnally selected: 12 (70.6%) were retrospective, while 5 (29.4%) were prospective, with an overall number of 877 included patients. most of the studies (14/17, 82.4%) employed [ 18F]-FDG as a radiopharmaceutical agent, 2 papers used [ 68Ga]-PSMA-11 and 1 employed mixed tracers. eleven studies were focused on protocols at low/ultralow activity or with fast/ultra-fast scanning time, 3 papers compared the performance of LAFOV PET/CT scanners with that of conventional (standard axial feld-of-view/SAFOV) devices, 4 were total-body PET dynamic studies. conclusions LAFOV PET/CT showed superior diagnostic performance than traditional SAFOV devices, allowing reduced activity/time and dynamic protocols. the applications of this novel technology in some clinical settings, mainly the pediatric population, are promising but should be a topic of future investigations

Filippi, L., Palumbo, B., Bagni, O., Frantellizzi, V., De Vincentis, G., Schillaci, O. (2023). DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review. LIFE, 13(1) [10.3390/life13010055].

DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review

Filippi, L;Schillaci, O
2023-01-01

Abstract

purpose to provide a comprehensive overview of the current main applications of long axial feld-of-view (LAFOV) PET/ CT in oncology. methods relevant studies published from 2017 up to september 2022 were selected by searching scopus, pubmed, and web of science. the following data were extracted: characteristics of studies and patients, technical aspects, and usefulness of the LAFOV PET/CT in the oncological setting. selected imaging studies were analyzed using a modifed version of the critical appraisal Skills Programme (CASP). results seventeen papers were fnally selected: 12 (70.6%) were retrospective, while 5 (29.4%) were prospective, with an overall number of 877 included patients. most of the studies (14/17, 82.4%) employed [ 18F]-FDG as a radiopharmaceutical agent, 2 papers used [ 68Ga]-PSMA-11 and 1 employed mixed tracers. eleven studies were focused on protocols at low/ultralow activity or with fast/ultra-fast scanning time, 3 papers compared the performance of LAFOV PET/CT scanners with that of conventional (standard axial feld-of-view/SAFOV) devices, 4 were total-body PET dynamic studies. conclusions LAFOV PET/CT showed superior diagnostic performance than traditional SAFOV devices, allowing reduced activity/time and dynamic protocols. the applications of this novel technology in some clinical settings, mainly the pediatric population, are promising but should be a topic of future investigations
2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-22/A - Diagnostica per immagini e radioterapia
English
Filippi, L., Palumbo, B., Bagni, O., Frantellizzi, V., De Vincentis, G., Schillaci, O. (2023). DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review. LIFE, 13(1) [10.3390/life13010055].
Filippi, L; Palumbo, B; Bagni, O; Frantellizzi, V; De Vincentis, G; Schillaci, O
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/390571
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? ND
social impact